Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia

2015218 citationsJournal Article

Authors

clinicaltrials.gov Identifier:NCT01529515.

Good health and well-being

Published in: JAMA Psychiatry

Volume 72, Issue 8, pp. 830-830

Field-Weighted Citation Impact: 15.06